| Lisa Hubbard, CFNP | |
|
5000 W Chambers St, Milwaukee, WI 53210-1650 | |
| (414) 447-2000 | |
| (414) 874-4393 |
| Full Name | Lisa Hubbard |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 5000 W Chambers St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013148980 | NPI | - | NPPES |
| 1013148980 | Other | WI | BLUE CROSS BLUE SHIELD |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Hubbard, CFNP 10625 W North Ave, Suite 102, Milwaukee, WI 53226-2315 Ph: (414) 877-5350 | Lisa Hubbard, CFNP 5000 W Chambers St, Milwaukee, WI 53210-1650 Ph: (414) 447-2000 |
News Archive
DiagnoCure Inc., a Quebec life sciences company that develops and commercializes high-value cancer diagnostic tests, reported that the PROGENSA PCA3 prostate cancer diagnostic test has been featured in a number of presentations and discussions at the American Urological Association (AUA) meeting in Atlanta, GA.
The new Concise Guide to PHARMACOLOGY 2015/2016 provides a valuable and unique overview of the key properties of more than 1,700 human drug targets, focusing on those exploited currently in the clinic or with future therapeutic potential.
The clinical symptoms of the severe COVID-19 have been well described. In addition, scientists have defined the post-acute COVID-19 as the development of sequelae or persistence of symptoms several weeks after the onset of COVID-19 symptoms. In some cases, the symptoms persist for around 3-4 weeks, and in other cases of chronic COVID-19, symptoms may persist beyond 12 weeks from the onset of symptoms.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
› Verified 8 days ago